Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 11986206

Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2002 May 15
First author
Kantarjian HM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kantarjian HM
      type
      Author
    2. name
      Cortes J
      type
      Author
    3. name
      O'Brien S
      type
      Author
    4. name
      Giles FJ
      type
      Author
    5. name
      Albitar M
      type
      Author
    6. name
      Rios MB
      type
      Author
    7. name
      Shan J
      type
      Author
    8. name
      Faderl S
      type
      Author
    9. name
      Garcia-Manero G
      type
      Author
    10. name
      Thomas DA
      type
      Author
    11. name
      Resta D
      type
      Author
    12. name
      Talpaz M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kantarjian HM
      type
      Author
    2. name
      Cortes J
      type
      Author
    3. name
      O'Brien S
      type
      Author
    4. name
      Giles FJ
      type
      Author
    5. name
      Albitar M
      type
      Author
    6. name
      Rios MB
      type
      Author
    7. name
      Shan J
      type
      Author
    8. name
      Faderl S
      type
      Author
    9. name
      Garcia-Manero G
      type
      Author
    10. name
      Thomas DA
      type
      Author
    11. name
      Resta D
      type
      Author
    12. name
      Talpaz M
      type
      Author
    bibliography ids
    1. nci-bib-020a9677cc0b54c93e3299fd
    book metadata
    content sha256
    4ce4c7f4401c755153fb95a251e620af8fe3cf5a844a20ceb8509bc130f0a4d3
    document type
    citation
    dois
    1. 10.1182/blood.v99.10.3547
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:11986206
    immutable id
    pubmed:11986206@4ce4c7f4401c755153fb95a251e620af8fe3cf5a844a20ceb8509bc130f0a4d3
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    10
    name
    Blood
    nlm unique id
    7603509
    pages
    3547-53
    volume
    99
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      11986206
      provenance
      batch id
      d4e82e28940c878dd0a2
      provider
      NCBI PubMed ESummary
      record sha256
      644d5c6c351771f7d8a5bd967ce7835aeabb359909ec7fd39abdc1db8a1e1d4f
      response sha256
      257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
      retrieved at
      2026-09-09T23:45:44.017762+00:00
      publication date
      display
      2002 May 15
      precision
      day
      year
      2002
      publication types
      1. Clinical Trial
      2. Comparative Study
      3. Controlled Clinical Trial
      4. Journal Article
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/11986206/
      title
      Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase.

      Preserved source evidence · Not medical advice